Modified M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) chemotherapy for advanced transitional cell carcinoma of the urothelium

Wilmosh Mermershtain, Avivit Neumann, Irina Gusakova, Igor Yusim, Endre Neulander, Konstantin Lavrenkov

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Modified M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) chemotherapy for advanced transitional cell carcinoma of the urothelium'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science